Hoth Therapeutics (HOTH)
(Delayed Data from NSDQ)
$0.90 USD
+0.03 (3.72%)
Updated Jul 8, 2024 03:51 PM ET
After-Market: $0.88 -0.02 (-2.47%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/9/24 |
---|---|
Current Quarter | -0.40 |
EPS Last Quarter | -0.46 |
Last EPS Surprise | -6.98% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.65 |
Next Year | -1.14 |
EPS (TTM) | -1.94 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.40 | -0.44 | -1.65 | -1.14 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -0.40 | -0.44 | -1.65 | -1.14 |
High Estimate | -0.40 | -0.44 | -1.65 | -1.14 |
Low Estimate | -0.40 | -0.44 | -1.65 | -1.14 |
Year ago EPS | -0.57 | -0.60 | -2.30 | -1.65 |
Year over Year Growth Est. | 29.82% | 26.67% | 28.26% | 30.91% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.40 | -0.44 | -1.65 | -1.14 |
7 Days Ago | -0.40 | -0.44 | -1.65 | -1.14 |
30 Days Ago | -0.40 | -0.44 | -1.65 | -1.14 |
60 Days Ago | -0.40 | -0.44 | -1.65 | -1.14 |
90 Days Ago | -0.40 | -0.44 | -1.65 | -1.14 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.40 | -0.44 | -1.65 | -1.14 |
Zacks Consensus Estimate | -0.40 | -0.44 | -1.65 | -1.14 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.46 | -0.31 | -0.60 | -0.57 | NA |
Estimate | -0.43 | NA | NA | NA | NA |
Difference | -0.03 | NA | NA | NA | -0.03 |
Surprise | -6.98% | NA | NA | NA | -6.98% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more